MADRIGAL PHARMACEUTICALS, INC. (MDGL) › EPS (Diluted)MADRIGAL PHARMACEUTICALS, INC. (MDGL) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2009: $2.322010: $-0.932011: $-1.002020: $-13.092021: $-14.632022: $-17.232023: $-19.992024: $-21.902025: $-12.85$-12.852009EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-12.85+41.3%2024$-21.90-9.6%2023$-19.99-16.0%2022$-17.23-17.8%2021$-14.63-11.8%2020$-13.09—2011$-1.00-7.5%2010$-0.93-140.1%2009$2.32—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share